Ebola response reveals colonial-era power imbalances in global health governance; Africa’s sovereignty in crisis management demands structural reform
Original framing: “Africa’s response to Ebola must be defined by Africa itself” — Financial Times
The 2014-2016 West African Ebola outbreak occurred against the backdrop of structural adjustment programs (1980s-90s) that dismantled public health systems, leaving Liberia, Sierra Leone, and Guinea with fewer than 50 doctors per million people. Colonial-era quarantine laws persist in modern biosecurity regimes, where Western 'expertise' is prioritized over African epidemiological data. The WHO’s delayed response to Ebola (2014) followed decades of underfunding its African regional office, a pattern repeating during COVID-19 with the exclusion of Africa from vaccine trials.
The Financial Times’ headline performs a rhetorical sleight-of-hand: it claims to center African agency while reproducing the colonial-era fiction that Africa lacks the capacity to define its own health security.
This framing obscures how decades of structural adjustment programs, patent monopolies, and underfunded African institutions (e.g., African CDC, WHO-AFRO) create the very vulnerabilities now framed as 'African failures.' The 2014 West African Ebola outbreak demonstrated that when African-led models (e.g., Nigeria’s 'àṣẹ'-based response) are empowered, containment rates exceed 99%, yet these successes are ignored in favor of Western 'expertise.' The real crisis is not Africa’s lack of agency, but the global health governance system’s refusal to cede power—whether through WHO funding structures, pharmaceutical monopolies, or the sidelining of indigenous knowledge. The solution lies not in 'support' but in structural reform: redirecting resources, breaking patent regimes, and recognizing African innovation as the foundation of global health security. This requires dismantling the trickster’s web—the illusion that Africa’s 'ownership' is compatible with Western control.